Genentech was founded in 1976 by Robert A. Swanson and Dr. Herbert W. Boyer. Genentech, now a member of the Roche Group, uses human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening conditions. It is among the world’s leading biotech companies and is considered to be the founder of the industry. Over the course of more than thirty-five years, the company has received many awards and recognization. Its purpose is to ‘do now what patients need next’. The goal is to make medicines that will be able to address unmet medical needs.